EASO clarifies respective roles of tirzepatide and semaglutide in obesity treatment

The European Association for the Study of Obesity clarifies the respective indications for two major obesity medications.

Published 8sem1 sourceNotable

≈ 21sSpeed

The fact

Tirzepatide and semaglutide offer different efficacies depending on patient profiles and therapeutic goals.

This clarification helps clinicians optimize treatment selection for each clinical situation.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on May 26, 2026